PEDIATRICS Vol. 93 No. 2 February 1994, pp. 278-283
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Marcaigh, A. S.
Right arrow Articles by Porter, C.-b. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Marcaigh, A. S.
Right arrow Articles by Porter, C.-b. J.

Tilt-Table Testing and Oral Metoprolol Therapy in Young Patients With Unexplained Syncope

Aengus S. O'Marcaigh MD1, Susan C. MacLellan-Tobert MD1, and Co-burn J. Porter MD1

1 Section of Pediatric Cardiology, Mayo Clinic and Mayo Foundation, Rochester, MN

Objective. Tilt-table testing is useful for investigating unexplained syncope in pediatric patients. No data are available on the use of intravenous metoprolol during testing to identify children who might respond to subsequent oral beta-adrenergic blockade or on the efficacy and safety of such oral therapy.

Design. To provide these data, we obtained follow-up information on 27 consecutive pediatric patients who had tilt-table testing for unexplained syncope.

Results. Nineteen patients (70%) had positive test results with or without isoproterenol infusion. All these patients had negative test results after intravenous infusion of metoprolol and subsequently were treated with oral metoprolol. Taking oral metoprolol therapy alone, 9 (47%) of the 19 patients were asymptomatic, 8 (42%) reported a decreased frequency of syncopal episodes, and 2 (11%) had unchanged or more frequent episodes. The mean dosage of metoprolol required to prevent symptoms was 1.5 mg/kg per day. Mild side effects were reported by 6 (32%) of the 19 patients. Six patients (32%) required additional medications.

Conclusions. We conclude that metoprolol is safe and effective for the treatment of most cases of neurocardiogenic syncope in children and that this response cannot be predicted accurately by the use of intravenous metoprolol during testing.

Submitted on April 9, 1993
Accepted on June 14, 1993




This article has been cited by other articles:


Home page
 Eur Heart JHome page
G. Foglia-Manzillo, F. Giada, N. Fteita, I. Nessi, M. Santarone, and A. Raviele
Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope
Eur. Heart J., November 1, 2007; 28(21): 2605 - 2609.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology
Europace, January 1, 2004; 6(6): 467 - 537.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. P. Moak, J. J. Bailey, and F. T. Makhlouf
Simultaneous heart rate and blood pressure variability analysis: Insight into mechanisms underlying neurally mediated cardiac syncope in children
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1466 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C.M. Seifer and R.A. Kenny
Head-up tilt testing in children
Eur. Heart J., November 1, 2001; 22(21): 1968 - 1971.
[PDF]

Home page
 PediatricsHome page
A. M. Kelly, C.-b. J. Porter, M. D. McGoon, R. E. Espinosa, M. J. Osborn, and D. L. Hayes
Breath-Holding Spells Associated With Significant Bradycardia: Successful Treatment With Permanent Pacemaker Implantation
Pediatrics, September 1, 2001; 108(3): 698 - 702.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al.
Guidelines on management (diagnosis and treatment) of syncope
Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306.
[Abstract] [PDF]

Home page
 QJMHome page
S.W. Parry and R.A. Kenny
The management of vasovagal syncope
QJM, December 1, 1999; 92(12): 697 - 705.
[Full Text] [PDF]

Home page
 PediatricsHome page
R. A. Rodriguez, K. Snider, G. Cornel, and O. H. P. Teixeira
Cerebral Blood Flow Velocity During Tilt Table Test for Pediatric Syncope
Pediatrics, August 1, 1999; 104(2): 237 - 242.
[Abstract] [Full Text]

Home page
 J Am Coll CardiolHome page
T. R. Burklow, J. P. Moak, J. J. Bailey, and F. T. Makhlouf
Neurally mediated cardiac syncope: autonomic modulation after normal saline infusion
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2059 - 2066.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
B C Galland, G Reeves, B J Taylor, and D P G Bolton
Sleep position, autonomic function, and arousal
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1998; 78(3): 189F - 194.
[Abstract] [Full Text]

Home page
 Arch Pediatr Adolesc MedHome page
A. K. Younoszai, W. H. Franklin, D. P. Chan, S. C. Cassidy, and H. D. Allen
Oral Fluid Therapy: A Promising Treatment for Vasodepressor Syncope
Arch Pediatr Adolesc Med, February 1, 1998; 152(2): 165 - 168.
[Abstract] [Full Text] [PDF]